Atea Pharmaceuticals (AVIR) Current Taxes (2021 - 2023)

Atea Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $23000.0 for Q2 2023.

• On a quarterly basis, Current Taxes rose 53.33% year-over-year to $23000.0 in Q2 2023; TTM through Jun 2023 was $23000.0, a 53.33% increase from a year earlier, with the FY2022 full-year figure at $99000.0, down 96.15% from the prior year.
• Current Taxes retreated to $23000.0 in Q2 2023 per AVIR's latest filing, from $178000.0 in the prior quarter.
• Across five years, Current Taxes topped out at $12.0 million in Q3 2021 and bottomed at $15000.0 in Q2 2022.
• The 3-year median for Current Taxes is $708000.0 (2022), against an average of $2.8 million.
• Across the five-year window, Current Taxes sank 99.79% in 2022 and soared 53.33% in 2023, its largest moves.
• Year by year, Current Taxes stood at $2.6 million in 2021, then slumped by 96.15% to $99000.0 in 2022, then tumbled by 76.77% to $23000.0 in 2023.
• Per Business Quant, the three latest AVIR Current Taxes figures stand at $23000.0 (Q2 2023), $178000.0 (Q1 2023), and $99000.0 (Q4 2022).